Charles Schwab’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $254K | Sell |
|
|||||
|
2025
Q2 | $259K | Sell |
|
|||||
|
2025
Q1 | $386K | Buy |
|
|||||
|
2024
Q4 | $480K | Buy |
|
|||||
|
2024
Q3 | $307K | Hold |
|
|||||
|
2024
Q2 | $514K | Buy |
|
|||||
|
2024
Q1 | $211K | Hold |
|
|||||
|
2023
Q4 | $224K | Hold |
|
|||||
|
2023
Q3 | $345K | Hold |
|
|||||
|
2023
Q2 | $364K | Buy |
|
|||||
|
2023
Q1 | $83.1K | Hold |
|
|||||
|
2022
Q4 | $67.6K | Hold |
|
|||||
|
2022
Q3 | $99K | Hold |
|
|||||
|
2022
Q2 | $79K | Sell |
|
|||||
|
2022
Q1 | $296K | Buy |
|
|||||
|
2021
Q4 | $749K | Hold |
|
|||||
|
2021
Q3 | $956K | Buy |
|
|||||
|
2021
Q2 | $933K | Buy |
|
|||||
|
2021
Q1 | $811K | Sell |
|
|||||
|
2020
Q4 | $585K | Buy |
|
|||||
|
2020
Q3 | $461K | Buy |
|
|||||
|
2020
Q2 | $457K | Buy |
|
|||||
|
2020
Q1 | $36K | Hold |
|
|||||
|
2019
Q4 | $35K | Hold |
|
|||||
|
2019
Q3 | $26K | Sell |
|
|||||
|
2019
Q2 | $35K | Sell |
|
|||||
|
2019
Q1 | $215K | Buy |
|
|||||
|
2018
Q4 | $90K | Sell |
|
|||||
|
2018
Q3 | $588K | Buy |
|
|||||
|
2018
Q2 | $447K | Buy |
|
|||||
|
2018
Q1 | $251K | Hold |
|
|||||
|
2017
Q4 | $242K | Sell |
|
|||||
|
2017
Q3 | $541K | Buy |
|
|||||
|
2017
Q2 | $392K | Buy |
|